HOUSTON, TX, June 13, 2024 (GLOBE NEWSWIRE) Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that its second generation (Gen-2), 15 milliamp (mA) neurostimulation device
HOUSTON, TX, May 22, 2024 Nexalin Technology, Inc. is pleased to announce its new division, Nexalin America, has been selected to join the National Traumatic Brain Injury Registry Coalition ..
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on May 23 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
HOUSTON, TEXAS, April 25, 2024 Nexalin Technology, Inc. announced that the Company received notice from The Nasdaq Stock Market on April 23, 2024, notifying the Company that it has regained.